AstraZeneca

Chris Curtis Excerpts

Monday 3rd February 2025 Commons Chamber

[Chris Bryant]

I will take support from wherever I can get it, so I am grateful to the right hon. Gentleman. It is a very simple point that when the Government invest in businesses of whatever kind, we have to make sure that we get value for money for the taxpayer, even when there is a very large cheque on the table. AstraZeneca decided to change the structure of its research and development, which is one of the reasons why we had to change the amount of money that we were prepared to put in, but the right hon. Gentleman’s other points are very good and well made.

[Chris Curtis (Milton Keynes North) (Lab)]

Alongside other Members representing Milton Keynes, I attended the Chancellor’s speech last Wednesday and spoke to many companies, including those from the life sciences sector. There were two really important points that they wanted to make, after being reasonably pleased with what they heard from the Chancellor. The first was about the importance of talking up our world-leading universities, after the previous Government continually talked them down. Will the Minister commit that this Government will continue to sell our world-leading universities, including Oxford and Cambridge, on the world stage?

The second point that companies wanted to make was that investing in life sciences right across the country requires a successful Oxford-Cambridge arc. Will the Minister commit to doing whatever it takes to make the entire corridor successful, including by getting a devolution deal for the midlands and speaking to his colleagues in the Ministry of Housing, Communities and Local Government to ensure that that happens?

[Chris Bryant]

Yes, and I agree with everything my hon. Friend says. The Oxford-Cambridge corridor is really important. Reading the newspapers over the weekend, I was intrigued by how many Conservative commentators kept on saying, “What I don’t understand is why the Conservatives didn’t do this over the last 14 years.” It is not enough simply to build the Oxford-Cambridge corridor; we need to make sure that we build on creative and scientific innovations at all our universities in the United Kingdom, and not just at Oxford and Cambridge.